In this episode of the Oncology Brothers podcast, we delved into the highlights from ASCO 2024, focusing on key studies in lung cancer. Dr. Joshua Sabari, a thoracic medical oncologist from NYU Langone Health, joined us to discuss the latest findings.
Overall, the episode emphasized the importance of precision medicine, the evolving landscape of treatment options in lung cancer, and the significance of multidisciplinary and patient-centered approaches in oncology practice.
Stay tuned for more highlights from ASCO 2024 across different cancer types in upcoming episodes. Thank you for listening to the Oncology Brothers podcast.